Reuven Avital
Corporate Officer/Principal chez Ma'Aragim Enterprises Ltd.
Profil
Reuven Avital is currently the General Manager & Partner at Ma'Aragim Enterprises Ltd.
He previously worked as the Director at Navidea Biopharmaceuticals, Inc. from 2002 to 2010 and as the Director at Cardiosonix Ltd.
in 2001.
Mr. Avital received his graduate degree from Harvard University and his undergraduate degree from The Hebrew University of Jerusalem.
Postes actifs de Reuven Avital
| Sociétés | Poste | Début |
|---|---|---|
| Ma'Aragim Enterprises Ltd. | Corporate Officer/Principal | - |
Anciens postes connus de Reuven Avital
| Sociétés | Poste | Fin |
|---|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 16/07/2010 |
Cardiosonix Ltd.
 Cardiosonix Ltd. Medical SpecialtiesHealth Technology Cardiosonix Ltd. develops surgical and medical equipment. The Israeli company was founded by Dan Manor. Cardiosonix was acquired by Navidea Biopharmaceuticals, Inc. on December 31, 2001 for $4.72 million. | Directeur/Membre du Conseil | 31/12/2001 |
Formation de Reuven Avital
| Harvard University | Graduate Degree |
| The Hebrew University of Jerusalem | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Ma'Aragim Enterprises Ltd. | |
Cardiosonix Ltd.
Cardiosonix Ltd. Medical SpecialtiesHealth Technology Cardiosonix Ltd. develops surgical and medical equipment. The Israeli company was founded by Dan Manor. Cardiosonix was acquired by Navidea Biopharmaceuticals, Inc. on December 31, 2001 for $4.72 million. | Health Technology |